MAY 29, 2018 7:30 AM PDT

Early Research Makes Connection Between Liver Tumor Growth Control and Gut Microbiota

WRITTEN BY: Mauri Brueggeman

As researchers learn more about the gut microbiome, they have focused attention on the interactions between the individual bacteria, the body, and immunity.  Researchers recently published work in Science sharing findings of a connection between the gut microbiome and liver tumor growth.

The gut microbiome, or gut microbiota, describes the diverse environment of microorganisms in the human and animal digestive tract.  Many studies have looked at the connections between the gut microbiome and human health and disease.  Its role is critical for human metabolism and affects nutrition, physiology and immune function.  It is widely accepted that there are hundreds of different species of bacteria that can make up an individual’s gut microbiota; in fact, at least a third are shared amongst a majority of people with the other two thirds being unique to each individual.  Our individual gut microbiome is like a fingerprint on the inside.

The murine study published in Science focused on the effects of antibiotics and gut microbiota in the presence of liver tumors.  The group used three different liver cancer types and reduced gastrointestinal bacteria with a combination of antibiotics.  The researchers found that by treating mice with liver tumors with antibiotics, they decreased particular bacteria and in turn, changed the make-up of immune cells in the liver.  The decreased number of bacteria induced an increase in natural killer T-cells which actually shrunk the liver tumors and acted as tumor suppressors.  In exploring this finding, the researchers determined that the accumulation of natural killer cells in the liver occurred due to increased expression of CXCL16, a protein found on the lining cells of liver capillaries.  In examining the role of CXCL16, the protein expression patterns were regulated by bile acids.  Increasing bile acids in mice changed the number of natural killer cells found in the liver and, therefore, could decrease the number of tumors in the liver.

The last connection made in this publication was that one specific bacterial species in the mouse microbiome controls metabolism of bile acids.  Clostridium scindens moderates CXCL16 expression, affects natural killer cell presence, and tumor cell growth within the environment of the liver.

The authors recognize that these results are just the beginning but lay the groundwork for future discoveries connecting the gut microbiome to key processes in our bodies that are, as of yet, unknown.

Sources: Science, National Cancer Institute, Gut Microbiota for Health,

About the Author
  • Mauri S. Brueggeman is a Medical Laboratory Scientist and Educator with a background in Cytogenetics and a Masters in Education from the University of Minnesota. She has worked in the clinical laboratory, taught at the University of Minnesota, and been in post secondary healthcare education administration. She is passionate about advances and leadership in science, medicine, and education.
You May Also Like
APR 09, 2021
Cancer
Employing machine-learning to identify the biological languages of cancer and Alzheimer's
APR 09, 2021
Employing machine-learning to identify the biological languages of cancer and Alzheimer's
In a study published in the scientific journal PNAS, researchers from St. John's College and the  University of ...
MAY 17, 2021
Cancer
Cells at the center of a tumor are more aggressive and spread faster
MAY 17, 2021
Cells at the center of a tumor are more aggressive and spread faster
New research stemming from a collaboration between researchers from the Francis Crick Institute, Royal Marsden, UCL and ...
MAY 27, 2021
Cancer
Which ovarian cancer patients will be resistant to platinum chemotherapy?
MAY 27, 2021
Which ovarian cancer patients will be resistant to platinum chemotherapy?
Research published in the journal EMBO Molecular Medicine details a novel mechanism that can be used to predict which ep ...
JUN 24, 2021
Clinical & Molecular DX
Test Lets Cancer Patients Track Whether Their Treatment Is Working in Real Time
JUN 24, 2021
Test Lets Cancer Patients Track Whether Their Treatment Is Working in Real Time
Researchers from Singapore have created the ExoSCOPE, the world’s first blood test for tracking whether or not a p ...
JUN 18, 2021
Cancer
Cancer cell lines are too dissimilar from human cancer cells
JUN 18, 2021
Cancer cell lines are too dissimilar from human cancer cells
A new study finds cultured cancer cells lack genetic similarity to humans. This is concerning because cancer cell lines ...
JUN 27, 2021
Cancer
Are e-cigarettes actually helpful for smoking cessation?
JUN 27, 2021
Are e-cigarettes actually helpful for smoking cessation?
New research published in The Lancet Public Health reports on a study that looked at interventions targeting e-cigarette ...
Loading Comments...